These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10609557)

  • 1. Comparison of DNA lesions produced by tumor-inhibitory 1,2-bis(sulfonyl)hydrazines and chloroethylnitrosoureas.
    Penketh PG; Shyam K; Sartorelli AC
    Biochem Pharmacol; 2000 Feb; 59(3):283-91. PubMed ID: 10609557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O6-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition.
    Penketh PG; Shyam K; Baumann RP; Remack JS; Brent TP; Sartorelli AC
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):279-87. PubMed ID: 14704831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA sequence selectivity of guanine-N7 alkylation by three antitumor chloroethylating agents.
    Hartley JA; Gibson NW; Kohn KW; Mattes WB
    Cancer Res; 1986 Apr; 46(4 Pt 2):1943-7. PubMed ID: 3004713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas.
    Stahl W; Krauth-Siegel RL; Schirmer RH; Eisenbrand G
    IARC Sci Publ; 1987; (84):191-3. PubMed ID: 2960614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of (2-haloethyl)nitrosoureas on DNA. Isolation and reactions of postulated 2-(alkylimino)-3-nitrosooxazolidine intermediates in the decomposition of 1,3-bis(2-chloroethyl)-, 1-(2-chloroethyl)-3-cyclohexyl-, and 1-(2-chloroethyl)-3-(4'-trans-methylcyclohexyl)-1-nitrosourea.
    Lown JW; Chauhan SM
    J Med Chem; 1981 Mar; 24(3):270-9. PubMed ID: 7265113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antineoplastic efficacy of the prodrug Cloretazine is produced by the synergistic interaction of carbamoylating and alkylating products of its activation.
    Baumann RP; Seow HA; Shyam K; Penketh PG; Sartorelli AC
    Oncol Res; 2005; 15(6):313-25. PubMed ID: 16408696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity.
    Baumann RP; Shyam K; Penketh PG; Remack JS; Brent TP; Sartorelli AC
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):288-95. PubMed ID: 14685775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Base sequence specificity of three 2-chloroethylnitrosoureas.
    Briscoe WT; Anderson SP; May HE
    Biochem Pharmacol; 1990 Sep; 40(6):1201-9. PubMed ID: 2403375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of O6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosoureas and 2-chloroethyl(methylsulfonyl)methanesulfonate.
    Dolan ME; Pegg AE; Hora NK; Erickson LC
    Cancer Res; 1988 Jul; 48(13):3603-6. PubMed ID: 2837318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of glutathione and glutathione S-transferases on DNA interstrand cross-link formation by 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine, the active anticancer moiety generated by laromustine.
    Penketh PG; Patridge E; Shyam K; Baumann RP; Zhu R; Ishiguro K; Sartorelli AC
    Chem Res Toxicol; 2014 Aug; 27(8):1440-9. PubMed ID: 25012050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of fluoroethylating agents is potentiated by O6-benzylguanine.
    Terashima I; Kohda K
    Biol Pharm Bull; 1996 Jul; 19(7):956-61. PubMed ID: 8839969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mammalian O6-alkylguanine-DNA alkyltransferase in a cell line sensitive to alkylating agents.
    Dolan ME; Norbeck L; Clyde C; Hora NK; Erickson LC; Pegg AE
    Carcinogenesis; 1989 Sep; 10(9):1613-9. PubMed ID: 2766456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation.
    Mitchell RB; Moschel RC; Dolan ME
    Cancer Res; 1992 Mar; 52(5):1171-5. PubMed ID: 1737376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.
    Dolan ME; Mitchell RB; Mummert C; Moschel RC; Pegg AE
    Cancer Res; 1991 Jul; 51(13):3367-72. PubMed ID: 1647266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstrand cross-linking of DNA by 1,3-bis(2-chloroethyl)-1-nitrosourea and other 1-(2-haloethyl)-1-nitrosoureas.
    Kohn KW
    Cancer Res; 1977 May; 37(5):1450-4. PubMed ID: 851960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU.
    Rice KP; Penketh PG; Shyam K; Sartorelli AC
    Biochem Pharmacol; 2005 May; 69(10):1463-72. PubMed ID: 15857610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea.
    Liu L; Markowitz S; Gerson SL
    Cancer Res; 1996 Dec; 56(23):5375-9. PubMed ID: 8968088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
    Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
    Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol).
    Bodell WJ; Bodell AP; Giannini DD
    Neuro Oncol; 2007 Jan; 9(1):12-9. PubMed ID: 17018699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.